2022 annual financial data
Cellectar Biosciences 2022 Operating margin
Cellectar Biosciences 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -28,813,773 USD and net income was -28,601,254 USD.
Operating cash flow was -25,222,301 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -28,813,773 USD
- Net income
- -28,601,254 USD
- Operating cash flow
- -25,222,301 USD